DOCSLIB.ORG

House of Lords Written Answers and Statements

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
House of Lords Written Answers and Statements Session 2019-21 Friday No. 205 19 March 2021 PARLIAMENTARY DEBATES (HANSARD) HOUSE OF LORDS WRITTEN ANSWERS Written Answers ................................ ..................... 3 [I] indicates that the member concerned has a relevant registered interest. The full register of interests can be found at http://www.parliament.uk/mps-lords-and-offices/standards-and-interests/register-of-lords-interests/ Members who want a printed copy of Written Answers and Written Statements should notify the Printed Paper Office. This printed edition is a reproduction of the original text of Answers and Statements, which can be found on the internet at http://www.parliament.uk/writtenanswers/. Ministers and others who make Statements or answer Questions are referred to only by name, not their ministerial or other title. The current list of ministerial and other responsibilities is as follows. Minister Responsibilities Baroness Evans of Bowes Park Leader of the House of Lords and Lord Privy Seal Earl Howe Deputy Leader of the House of Lords Lord Agnew of Oulton Minister of State, Treasury and Cabinet Office Lord Ahmad of Wimbledon Minister of State, Foreign, Commonwealth and Development Office Lord Ashton of Hyde Chief Whip Baroness Barran Parliamentary Under-Secretary of State, Department for Digital, Culture, Media and Sport Baroness Berridge Parliamentary Under-Secretary of State, Department for Education and Department for International Trade Lord Bethell Parliamentary Under-Secretary of State, Department of Health and Social Care Baroness Bloomfield of Hinton Whip Waldrist Lord Callanan Parliamentary Under-Secretary of State, Department for Business, Energy and Industrial Strategy Earl of Courtown Deputy Chief Whip Lord Frost Minister of State, Cabinet Office Lord Gardiner of Kimble Parliamentary Under-Secretary of State, Department for Environment, Food and Rural Affairs Baroness Goldie Minister of State, Ministry of Defence Lord Goldsmith of Richmond Park Minister of State, Department for Environment, Food and Rural Affairs and Foreign, Commonwealth and Development Office Lord Greenhalgh Minister of State, Home Office and Ministry of Housing, Communities and Local Government Lord Grimstone of Boscobel Minister of State, Department of Business, Energy and Industrial Strategy and Department for International Trade Lord Parkinson of Whitley Bay Whip Baroness Penn Whip Baroness Scott of Bybrook Whip Baroness Stedman-Scott Parliamentary Under-Secretary of State, Department for Work and Pensions Lord Stewart of Dirleton Advocate-General for Scotland Lord True Minister of State, Cabinet Office Baroness Vere of Norbiton Parliamentary Under-Secretary of State, Department for Transport Baroness Williams of Trafford Minister of State, Home Office Lord Wolfson of Tredegar Parliamentary Under-Secretary of State, Ministry of Justice Viscount Younger of Leckie Whip © Parliamentary Copyright House of Lords 2021 This publication may be reproduced under the terms of the Open Parliament licence, which is published at www.parliament.uk/site-information/copyright/ Index to Answers Written Answers Asked by Lord Jones of Cheltenham To ask Her Majesty's Government what plans they Friday, 19 March 2021 have to vaccinate patients who are in hospital for reasons other than for treatment for COVID-19. [HL11743] Business: VAT Lord Bethell: Hospital hubs will typically vaccinate Asked by Lord Taylor of Warwick eligible inpatients or eligible outpatients due to attend To ask Her Majesty's Government what assessment hospital where clinically appropriate. they have made of the business readiness survey by Asked by Lord Bourne of Aberystwyth Ready for Brexit, published on 9 March; and what plans they have to provide detailed guidance to businesses on To ask Her Majesty's Government what plans they VAT reporting requirements. [HL14115] have to make it easier to use volunteers to support the COVID-19 vaccination programme. [HL11864] Lord Agnew of Oulton: The Government has provided extensive guidance to businesses on VAT, excise, and Lord Bethell: We are working with the Royal customs processes to support them in their readiness for Voluntary Service and St John Ambulance to recruit and the UK leaving the EU. This guidance includes videos, train thousands more volunteer vaccinators, who will have webinars and step-by-step guides. HMRC listen carefully all the relevant clinical training, as well as supervision, to to feedback and have introduced additional products on ensure they can vaccinate in a way that is safe for patients Rules of Origin, and the Government has also announced and for themselves. This includes drawing on the skills of a £20 million SME Brexit Support Fund. those who have volunteered through the NHS Bring Back Scheme, considering the use of a wider range of medical HMRC continue to work closely with a wide range of professionals as well as those currently working outside business representative organisations and trade of the National Health Service. associations to help businesses engage with new requirements, including through the latest public Ongoing recruitment for both the clinical and non- information campaign, cross-Government industry clinical volunteering roles is via the NHS Volunteer steering groups and events. Responder GoodSAM app. Requests for volunteer support for the COVID-19 vaccination programme are being directed through the lead provider in each area. Coronavirus: Vaccination Asked by Baroness Grey-Thompson Asked by Baroness Deech To ask Her Majesty's Government what provision To ask Her Majesty's Government what plans they they have made to ensure that vaccination venues are have to collect evidence of the effectiveness of the accessible for disabled people; and how that second dose of the Pfizer/BioNTech COVID-19 information is made available when booking tests. vaccination being administered more than 21 days after [HL12959] the first. [HL11727] Lord Bethell: Vaccination centres are subject to the Lord Bethell: Based on the data available to the Joint same standards to support people with accessibility needs Committee on Vaccination and Immunisation the first as all health care services. In addition, marshals and staff dose of either Pfizer/BioNTech or Oxford/AstraZeneca will help people attending vaccination centres to navigate vaccine provides substantial protection within two to safely. three weeks of in particular for severe COVID-19 disease. When sent an invitation for vaccination by letter, the The second vaccine dose is likely to be more important public are directed to the location's individual details on for duration and sustaining such protection. An accessibility. The letter also provides guidance and advice appropriate dose interval may further increase vaccine which can be enlarged on a screen, provided in accessible efficacy. In the short term, the additional increase of formats as well as provided in hard copy. vaccine efficacy from the second dose is likely to be modest as the great majority of the initial protection from Asked by Baroness Masham of Ilton clinical disease is after the first dose of vaccine. To ask Her Majesty's Government what plans they Public Health England (PHE) is monitoring the have to include people paralysed with spinal cord effectiveness of the vaccines in the real world, including injuries and who have not received a vaccine in the the effects of dosage schedules. Early data from PHE’s second phase priority vaccination groups. [HL13473] SIREN study shows a promising impact of vaccination on Lord Bethell: Prioritisation for phase two has not yet infection in healthcare workers aged under 65 years old. been decided. However the Joint Committee on Data shows one dose reduces the risk of catching Vaccination and Immunisation’s (JCVI) interim advice infection by more than 70%, rising to 85% after the recommends an age-based approach, which the second dose of the Pfizer vaccine. Government has accepted in principle. Index to Answers The JCVI has advised that phase two will include all Lord Bethell: For phase two of the COVID-19 adults under 50 years old who were not included in phase vaccination programme, the Joint Committee on one, starting with the oldest adults first. The JCVI’s Vaccination and Immunisation’s (JCVI) interim advice interim advice has not indicated that, as a group, persons sets out that the most effective way to minimise paralysed with spinal cord injuries are at higher risk from hospitalisations and deaths is to continue to prioritise COVID-19 and therefore they have not been prioritised people by age, as it is assessed to be the strongest factor for the COVID-19 vaccine programme. Final advice on linked to mortality, morbidity and hospitalisation. phase two will be published by the JCVI in due course. Prison staff will not therefore be prioritised in phase Asked by Lord Mendelsohn two of the COVID-19 vaccine programme. However, in order to minimise vaccine wastage in delivery of the To ask Her Majesty's Government what plans they programme, the JCVI has advised that where vaccines have to monitor the effectiveness of vaccines at remain unused following an offer of vaccination to those preventing transmission of COVID-19, and when they in detained settings, such vaccine it could reasonably be expect to be able to assess whether vaccines are offered to prison officers. preventing transmission. [HL13923] Lord Bethell: Public Health England (PHE) is monitoring the impact of COVID-19 vaccines on a broad Covid-19 Corporate Financing Facility range of outcomes, including symptomatic
Load more

Recommended publications
  • Annual Report and Accounts 2017/18
    !""#$%&'()*'+&$",&$--*#"+.&/012314& &&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&&5#6$"&78..#(&!#+9*'8+:&&& ! ! & & & & & & & & & & & & Annual report and accounts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
    [Show full text]
  • Annual Report
    Our 2018/19 Annual Report Health and high quality care for all, now and for future generations HC 2293 NHS England Annual Report and Accounts 2018/19 NHS England is legally referred to as the National Health Service Commissioning Board. Presented to Parliament pursuant to the National Health Service Act 2006 (as amended by the Health and Social Care Act 2012). Ordered by the House of Commons to be printed 11 July 2019 HC 2293 © Crown copyright 2019 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. This publication is available at www.gov.uk/official-documents Any enquiries regarding this publication should be sent to us at: NHS England, Quarry House, Quarry Hill, Leeds, LS2 7UE. ISBN 978-1-5286-1036-0 CCS0219647926 07/19 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office Contents A view from Lord David Prior, Chair ............................................................................7 About NHS England ......................................................................................................9 Performance Report ......................................................................................................13 Chief Executive’s
    [Show full text]
  • Clinical Negligence Cases in the English NHS: Uncertainty in Evidence As a Driver of Settlement Costs and Societal Outcomes
    Health Economics, Policy and Law (2021), page 1 of 16 doi:10.1017/S1744133121000177 ARTICLE Clinical negligence cases in the English NHS: uncertainty in evidence as a driver of settlement costs and societal outcomes Alexander W. Carter1* , Elias Mossialos1,2 , Julian Redhead3 and Vassilios Papalois3,4 1Department of Health Policy, London School of Economics & Political Science, London, UK, 2Institute of Global Health Innovation, Imperial College London, London, UK, 3Imperial College Healthcare NHS Trust, London, UK and 4Department of Surgery & Cancer, Faculty of Medicine, Imperial College London, London, UK *Corresponding author. Email: [email protected] (Received 1 May 2020; revised 15 March 2021; accepted 17 March 2021) Abstract The cost of clinical negligence claims continues to rise, despite efforts to reduce this now ageing burden to the National Health Service (NHS) in England. From a welfarist perspective, reforms are needed to reduce avoidable harm to patients and to settle claims fairly for both claimants and society. Uncertainty in the estimation of quanta of damages, better known as financial settlements, is an important yet poorly char- acterised driver of societal outcomes. This reflects wider limitations to evidence informing clinical negli- gence policy, which has been discussed in recent literature. There is an acute need for practicable, evidence-based solutions that address clinical negligence issues, and these should complement long-stand- ing efforts to improve patient safety. Using 15 claim cases from one NHS Trust between 2004 and 2016, the quality of evidence informing claims was appraised using methods from evidence-based medicine. Most of the evidence informing clinical negligence claims was found to be the lowest quality possible (expert opinion).
    [Show full text]
  • Annual Report and Accounts 2018/19 Human Tissue Authority
    Annual report and accounts 2018/19 Human Tissue Authority Annual report and accounts 2018/19 Annual report and accounts 2018/19 Human Tissue Authority Human Tissue Authority Annual report and accounts 2018/19 Presented to Parliament pursuant to Schedule 2(16) of the Human Tissue Act 2004. Ordered by the House of Commons to be printed on 27 June 2019 HC 2325 Annual report and accounts 2018/19 Human Tissue Authority © Human Tissue Authority copyright 2019 This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3. Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned. Any enquiries related to this publication should be sent to us at [email protected] This publication is available at www.gov.uk/official-documents ISBN 978-1-5286-1143-5 CCS0319877000 06/19 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the APS Group on behalf of the Controller of Her Majesty’s Stationery Office Annual report and accounts 2018/19 Human Tissue Authority Contents Foreword 6 Performance 8 Overview ....................................................................................................................................... 9 Performance analysis ................................................................................................................ 16 Accountability 22 Corporate governance
    [Show full text]
  • NHS England and NHS Improvement Is the Umbrella Body That Oversees Healthcare
    “No society can legitimately call itself civilised if a sick person is denied medical aid because of lack of means” 1962 hospital 1990 internal 2012 Lansley 2019 long plan market reforms term plan NHS is 1974 health 2000 NHS 2014 5-year born authorities plan forward view • Medicines & Healthcare products • NHS Blood and Transplant Regulatory Agency • NHS Business Services Authority • Public Health England • NHS Resolution • NHS Counter Fraud Authority Commissioners Central Support and Improvement Regulators • NHS England/NHS Improvement • National Institute of Health and Care Excellence • Care Quality Commission • Health Education England • NHS England/NHS Improvement • NHS Digital • Human Fertilisation and Embryology Authority • Human Tissue Authority • Health Research Authority ▪ The Department for Health and Social Care is the government department responsible for funding and coming up with policies to do with healthcare in the UK. ▪ NHS England and NHS Improvement is the umbrella body that oversees healthcare. It is an independent body, which means that the Department for Health cannot interfere directly with its decisions. ▪ Clinical Commissioning Groups (CCGs) are responsible for commissioning healthcare for their local area. They are run by GPs, nurses and consultants who assess local health needs and commission the services to meet them. They are in charge of around 60% of the NHS budget. ▪ NHS Foundation Trusts and NHS Trusts provide the care that the CCGs commission. They include hospital, ambulance, mental health, social care
    [Show full text]
  • NHS Richmond Clinical Commissioning Group’S Annual Report for the Financial Year 2018/19
    Richmond Clinical Commissioning Group Annual Report and Financial Accounts 2018/19 Contents PERFORMANCE REPORT Welcome from Accountable Officer and Chair Page 3 Performance overview Page 4 Corporate objectives Page 4 The Richmond story Page 6 Summary of achievements during 2018/19 Page 8 Performance analysis Monitoring the quality of health services Page 29 Patient advice and liaison services and complaints Page 30 Freedom of Information (FOI) Page 31 Performance summary Page 31 Sustainability report Page 37 Patient and public engagement (PPE) Page 40 Equality report Page 47 Reducing health inequalities Page 47 Health and wellbeing strategy Page 53 ACCOUNTABILITY REPORT Corporate governance report Members’ report Page 58 Statement of Accountable Officer’s responsibilities Page 75 Governance statement Page 77 Risk management arrangements and effectiveness Page 79 Head of internal audit opinion Page 87 Remuneration and staff report Remuneration report Page 91 Staff report Page 98 Parliamentary accountability and audit report Page 107 Annual Accounts Annex 1 External Audit Opinion Annex 2 2 | Page Welcome from Accountable Officer and Chair Welcome to NHS Richmond Clinical Commissioning Group’s Annual Report for the financial year 2018/19. We have been working as part of the South West London Alliance with our partners Kingston, Sutton, Merton and Wandsworth CCGs for two years now, sharing expertise and making more efficient use of resources. Richmond and Kingston CCGs have also been working together during this time as a local delivery unit within the Alliance headed by Tonia Michaelides as Managing Director. Merton and Wandsworth CCGs have also been operating in this way. In July 2018, the NHS turned 70 and we celebrated the occasion with a range of activities with our partners across the borough.
    [Show full text]
  • Framework Agreement Between the Department of Health and Social Care and NHS Resolution
    Framework Agreement between the Department of Health and Social Care and NHS Resolution Published January 2021 Contents 1. Purpose of this document .............................................................................................. 3 2. Purpose of NHS Resolution .......................................................................................... 4 3. Governance ................................................................................................................... 6 Process for setting objectives ........................................................................................... 6 Discharge of statutory functions ....................................................................................... 7 Cross-government clearance............................................................................................ 7 4. Accountability ................................................................................................................ 8 Secretary of State ............................................................................................................. 8 Sponsor department's accounting officer's specific accountabilities and responsibilities as Principal Accounting Officer (PAO) .............................................................................. 8 Responsibilities of NHS Resolution's Chief Executive as Accounting Officer ................... 9 Reviewing performance .................................................................................................. 10
    [Show full text]
  • Annual Report and Accounts 2016/17
    HC 172 Annual report and accounts 2016/17 Advise / Resolve / Learn NHS Resolution Annual report and accounts 2016/17 Presented to Parliament pursuant to Paragraph 6 of Schedule 15 of the National Health Service Act 2006. Ordered by the House of Commons to be printed 13 July 2017. This is a reproduction of the annual report and accounts laid before Parliament under the name of the NHS Litigation Authority - pages 5 to 165 remain unchanged HC 172 Contents © NHS Resolution 2017 (the operating name of the NHS Litigation Authority) The text in this document (this excludes, where present, the Royal Arms and all departmental or agency logos) may be reproduced free of charge in any format or medium provided that it is reproduced accurately and not in a misleading context. The material must be acknowledged as NHS Resolution copyright and the document title specified. Where third party material has been identified, permission from the respective copyright holder much be sought. Any enquiries related to this publication should be sent to us at 151 Buckingham Palace Road, London, SW1W 9SZ This publication is available at www.gov.uk/government/publications Print ISBN 9781474143813 Web ISBN 9781474143820 ID 18041725 07/17 Printed on paper containing 75% recycled fibre content minimum Printed in the UK by the Williams Lea Group on behalf of the Controller of Her Majesty’s Stationery Office Advise / Resolve / Learn Contents Contents Performance report 6 Chair’s welcome 8 Chief Executive’s report 10 Performance summary 12 What we do 12 Understanding our
    [Show full text]
  • NHSE/I's System Oversight Framework 2021/22 Consultation
    NHS Resolution response to: NHSE/I’s System Oversight Framework 2021/22 Consultation Submitted: Friday 14 May 2021 About NHS Resolution NHS Resolution is an arm’s-length body of the Department of Health and Social Care. We provide expertise to the NHS on resolving concerns and disputes fairly, sharing learning for improvement and preserving resources for patient care. Our main functions are: Claims Management: dealing with claims for compensation on behalf of the NHS in England. The bulk of our workload is handling negligence claims on behalf of the members of our indemnity schemes: NHS organisations and independent sector providers of NHS care in England and since April 2019, beneficiaries of state-backed indemnity for general practice; Practitioner Performance Advice: managing concerns raised about the performance of doctors, dentists and pharmacists; Primary Care Appeals: dealing with appeals and disputes between primary care contractors and NHS England; and Safety and Learning: helping providers of NHS care to understand their own claims risk profiles to target safety activity and share learning across the health service nationwide. Response to consultation Question: Do you agree that the proposed approach to oversight set out in this document meets the purposes and principles set out in section 2: 'Purpose and Principles'? If not, how could the proposed approach be improved? 1. NHS Resolution is supportive of the purpose and principles of NHS England/Improvement’s (NHSE/I) framework, particularly its plan to “provide an objective basis for decisions about when and how NHS England and NHS Improvement will intervene in cases where there are serious problems or risks to the quality of care”.1 2.
    [Show full text]
  • Becton Dickinson Blood Specimen Collection - Supply Disruption
    Classification: Official Publication approval reference: B0933 To: All GPs in England. NHS England and NHS Improvement Pathology Incident Directors Skipton House Trust Chief Executives 80 London Road Trust EPRR leads London Trust Medical Directors SE1 6LH Trust Directors of Nursing Trust Procurement leads 26 August 2021 CCG Accountable Officers CCG EPRR leads CCG Medical leads CCG Procurement leads CCG Directors of Nursing ICS leads STP leads Dear Colleague, Becton Dickinson blood specimen collection - supply disruption Becton Dickinson has alerted us to a shortage of products from their Blood Specimen Collection Portfolio that is impacting across most main blood tube supplies. Working closely with DHSC, NHS Supply Chain, the MHRA and colleagues from the devolved administrations, given the impact on other parts of the UK, NHS England and NHS Improvement is co-ordinating the NHS’ response in England, on a national basis. The supply position remains constrained and is forecasted to become even more constrained over the coming weeks. While it is anticipated that the position will improve from the middle of September, overall supply is likely to remain challenging for a significant period. We have previously sent information in relation to this issue and will continue to provide updates as the supply situation develops. The tubes impacted by this shortage are: 1. 5mls Yellow top – SST 2 – clotted sample (e.g. U&E, LFTs etc) 2. Purple top – EDTA (e.g. FBC, HbA1c) Alternative products are being sought to alleviate these constraints; and all labs that will be switching to these supplies have received samples for testing and validation. However, it will take time for these products to be imported and delivered in volume to services.
    [Show full text]
  • Ask Listen Do Making Conversations Count in Health, Social Care and Education
    Ask Listen Do Making conversations count in health, social care and education Tips for health, social care and education organisations and practitioners Making feedback, concerns and complaints easier for people with a learning disability, autistic people, families and carers. NHS England in partnership with the Local Government & Social Care Ombudsman, Local Government Association, Parliamentary and Health Service Ombudsman, Care Quality Commission, Department for Education, Department for Health and Social Care, NHS Improvement, Ofsted, PBS4 and Inclusion East CIC OFFICIAL NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation Finance Publications Gateway Reference: 08451 Document Purpose Guidance Document Name Ask Listen Do Resource for Organisations and Practitioners NHS England / Nursing Directorate / Learning Disability Programme / Author Improving Health and Quality Publication Date 31 October 2018 Target Audience CCG Clinical Leaders, CCG Accountable Officers, CSU Managing Directors, Care Trust CEs, Foundation Trust CEs , Medical Directors, Directors of PH, Directors of Nursing, Local Authority CEs, Directors of Adult SSs, NHS Trust Board Chairs, NHS England Regional Directors, NHS England Directors of Commissioning Operations, All NHS England Employees, Directors of HR, Directors of Finance, Allied Health Professionals, GPs, Communications Leads, Emergency Care Leads, Directors of Children's Services, NHS Trust CEs Additional
    [Show full text]
  • PRESS STATEMENT Embargoed Until 00:01Am Monday 10 September
    PRESS STATEMENT 07 September 2018 Embargoed until 00:01am Monday 10 September 2018 NHS Resolution reviews suicide-related claims to help prevent future harm NHS Resolution is calling for improvements and better integration across the NHS and mental health services to ensure at risk patients are given more support and care having carried out a thematic review of suicide-related claims. The report, launched to coincide with World Suicide Prevention Day on 10 September 2018, Learning from suicide-related claims: a thematic review of NHS Resolution data, examines some of the factors that contribute to suicide claims and the quality of investigations following these tragic incidents. 101 deaths occurring between 2010 and 2017 were examined in-detail. The NHS trusts involved in these cases were supported through NHS Resolution’s inquest scheme[1]. In addition 25 claims relating to non-fatal suicide attempts were also analysed for comparison. To reduce the risk of suicide-related incidents and to improve the response of trusts, NHS Resolution has made nine recommendations for NHS trusts and national bodies. The recommendations highlight potential learning for those delivering mental health services in England. Where recommendations explicitly reference bodies external to NHS Resolution, we have worked with them to agree the relevant recommendation and are grateful for their support and commitment to action them. Working in partnership with organisations including the Royal College of Psychiatrists, NHS England, NHS Improvement, Her Majesty’s Prison and Probation Service, and families and staff members affected by suicide, the study draws on the unique dataset held by NHS Resolution to explore best practice and key areas such as: the shared clinical characteristics of those ending their lives by suicide that result in a claim for compensation; and how well families, carers and staff are supported following suicide; and the investigation process.
    [Show full text]